Andrew Dufresne, Autumn Nero, Dan Bagatell and Shannon Bloodworth were mentioned in the Law360* article, "Fed. Circ. Kills 2 Patents on Horizon Pain Drug Vimovo," as representation for Mylan when the U.S. Court of Appeals for the Federal Circuit ruled that two patents on Horizon Pharma's Vimovo are invalid.

*Subscription-based publication